The tick saliva immunosuppressor, Salp15, contributes to Th17-induced pathology during Experimental Autoimmune Encephalomyelitis

Biochemical and Biophysical Research Communications

Volumn 402, Issue 1, 2010, Pages 105-109

  Juncadella, Ignacio J ^a,b   Bates, Tonya C ^a,c   Suleiman, Reem ^a   Monteagudo Mera, Andrea ^a   Olson, Chris M ^a,d   Navasa, Nicolás ^a   Olivera, Elias R ^a,e   Osborne, Barbara A ^a   Anguita, Juan ^a  

^a UNIVERSITY OF MASSACHUSETTS   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

^c UNIVERSITY OF NORTH CAROLINA AT CHARLOTTE   (United States)

^d WALTER REED ARMY MEDICAL CENTER   (United States)

^e UNIVERSITY OF LEÓN   (Spain)

Author keywords

Autoimmunity; EAE; IL 2; Salp15; Th17 differentiation

Indexed keywords

GAMMA INTERFERON; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 17; INTERLEUKIN 2; INTERLEUKIN 6; PEPTIDE ANTIBODY; SALIVA PROTEIN; SALP15 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ARTICLE; BLOOD BRAIN BARRIER; CD4+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE SEVERITY; FEMALE; IMMUNOMODULATION; IMMUNOSTIMULATION; IN VIVO STUDY; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTIC INFILTRATION; MEMBRANE PERMEABILITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS INHIBITION; T LYMPHOCYTE ACTIVATION; TH17 CELL;

ANIMALS; B-LYMPHOCYTES; BLOOD-BRAIN BARRIER; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; IMMUNE TOLERANCE; IMMUNOSUPPRESSIVE AGENTS; INTERLEUKIN-17; MICE; MICE, INBRED STRAINS; PERMEABILITY; SALIVARY PROTEINS AND PEPTIDES; TH1 CELLS;

ANIMALIA; IXODIDA; MURINAE; MUS;

EID: 78049307982     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2010.09.125     Document Type: Article

References (31)

1. + T cell activation. Immunity 2002, 16:849-859.
2. Garg R., Juncadella I.J., Ramamoorthi N., Ashish, Ananthanarayanan S.K., Thomas V., Rincon M., Krueger J.K., Fikrig E., Yengo C.M., Anguita J. Cutting edge: CD4 is the receptor for the tick saliva immunosuppressor, salp15. J. Immunol. 2006, 177:6579-6583.
3. Ashish, Juncadella I.J., Garg R., Boone C.D., Anguita J., Krueger J.K. Conformational rearrangement within the soluble domains of the CD4 receptor is ligand-specific. J. Biol. Chem. 2008, 283:2761-2762.
4. Juncadella I.J., Garg R., Ananthanarayanan S.K., Yengo C.M., Anguita J. T cell signaling pathways inhibited by the tick saliva immunosuppressor, Salp15. FEMS Immunol. Med. Microbiol. 2007, In press.
5. Paveglio S.A., Allard J., Mayette J., Whittaker L.A., Juncadella I., Anguita J., Poynter M.E. The tick salivary protein, Salp15, inhibits the development of experimental asthma. J. Immunol. 2007, 178:7064-7071.
6. McRae B.L., Kennedy M.K., Tan L.J., Dal Canto M.C., Picha K.S., Miller S.D. Induction of active and adoptive relapsing experimental autoimmune encephalomyelitis (EAE) using an encephalitogenic epitope of proteolipid protein. J. Neuroimmunol. 1992, 38:229-240.
7. Lehmann P.V., Forsthuber T., Miller A., Sercarz E.E. Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen. Nature 1992, 358:155-157.
8. McRae B.L., Vanderlugt C.L., Dal Canto M.C., Miller S.D. Functional evidence for epitope spreading in the relapsing pathology of experimental autoimmune encephalomyelitis. J. Exp. Med. 1995, 182:75-85.
9. Yu M., Johnson J.M., Tuohy V.K. A predictable sequential determinant spreading cascade invariably accompanies progression of experimental autoimmune encephalomyelitis: a basis for peptide-specific therapy after onset of clinical disease. J. Exp. Med. 1996, 183:1777-1788.
10. Goverman J., Brabb T. Rodent models of experimental allergic encephalomyelitis applied to the study of multiple sclerosis. Lab Anim. Sci. 1996, 46:482-492.
11. Aggarwal S., Ghilardi N., Xie M.H., de Sauvage F.J., Gurney A.L. Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17. J. Biol. Chem. 2003, 278:1910-1914.
12. El-behi M., Rostami A., Ciric B. Current views on the roles of Th1 and Th17 cells in experimental autoimmune encephalomyelitis. J. Neuroimmune Pharmacol. 2010, 5:189-197.
13. Iwakura Y., Ishigame H. IL-23/Il-17 axis in inflammation. J. Clin. Invest. 2006, 116:1218-1222.
14. Park H., Li Z., Yang X.O., Chang S.H., Nurieva R., Wang Y.H., Wang Y., Hood L., Zhu Z., Tian Q., Dong C. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat. Immunol. 2005, 6:1133-1141.
15. Komiyama Y., Nakae S., Matsuki T., Nambu A., Ishigame H., Kakuta S., Sudo K., Iwakura Y. IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis. J. Immunol. 2006, 177:566-573.
16. Langrish C.L., Chen Y., Bumenschein W.M., Mattson J., Basham B., Sedgwick J.D., McClanahan T., Kastelein R.A., Cua D.J. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J. Exp. Med. 2005, 201:233-240.
17. Bettelli E., Carrier Y., Gao W., Korn T., Strom T.B., Oukka M., Weiner H.L., Kuchroo V.K. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 2006, 441:235-238.
18. Mangan P.R., Harrington L.E., O'Quinn D.B., Helms W.S., Bullard D.C., Elson C.O., Hatton R.D., Wahl S.M., Schoeb T.R., Weaver C.T. Transforming growth factor-beta induces development of the T(H)17 lineage. Nature 2006, 441:231-234.
19. Veldhoem M., Hocking R.J., Atkins C.J., Locksley R.M., Stockinger B. TGF-beta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17 producing T cells. Immunity 2006, 24:179-189.
20. Ivanov, McKenzie B.S., Zhou L., Tadokoro C.E., Lepelley A., Lafaille J.J., Cua D.J., Littman D.R. The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell 2006, 126:1121-1133.
21. Yang X.O., Pappu B.P., Nurieva R., Akimzhanov A., Kang H., Chung Y., Ma L., Shah B., Panopoulos A.D., Schluns K., Watowich S.S., Tian Q., Jetten A.M., Dong C. T helper 17 lineage differentiation is programmed by orphan nuclear receptor ROR alpha and ROR gamma. Immunity 2008, 28:29-39.
22. Tuohy V.K., Lu Z., Sobel R.A., Laursen R.A., Lees M.B. Identification of an encephalitogenic determinant of myelin proteolipid protein for SJL mice. J. Immunol. 1989, 142:1523-1527.
23. Olson C.M., Bates T.C., Izadi H., Radolf J.D., Huber S.A., Boyson J.E., Anguita J. Local production of IFN-{gamma} by invariant NKT cells modulates acute lyme carditis. J. Immunol. 2009, 182:3728-3734.
24. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001, 25:402-408.
25. Weber M.S., Hemmer B., Cepok S. The role of antibodies in multiple sclerosis. Biochim. Biophys. Acta 2010.
26. Laurence A., Tato C.M., Davidson T.S., Kanno Y., Chen Z., Yao Z., Blank R.B., Meylan F., Siegel R., Hennighausen L., Shevach E.M., O'Shea J J. Interleukin-2 signaling via STAT5 constrains T helper 17 cell generation. Immunity 2007, 26:371-381.
27. + T cells. J. Exp. Med. 1997, 185:461-469.
28. Sakaguchi S., Sakaguchi N. Thymus and autoimmunity. Transplantation of the thymus from cyclosporine A-treated mice causes organ-specific autoimmune disease in athymic mice. J. Exp. Med. 1988, 167:1479-1485.
29. Blazar B.R., Taylor P.A., Snover D.C., Sehgal S.N., Vallera D.A. Murine recipients of fully mismatched donor marrow are protected from lethal graph-versus-host disease by in vivo administration of rapamycin but develop an autoimmune-like syndrome. J. Immunol. 1993, 151:5726-5741.
30. Bucy R.P., Xu X.Y., Li J., Huang G. Cyclosporin A-induced autoimmunity disease in mice. J. Immunol. 1993, 151:1039-1050.
31. Chen W., Thoburn C., Hess A.D. Characterization of the pathogenic autoreactive T cells in cyclosporine-induced syngeneic graft-versus-host disease. J. Immunol. 1998, 15:7040-7046.